{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T02:17:38Z","timestamp":1793413058030,"version":"4.5.0"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,2,9]],"date-time":"2021-02-09T00:00:00Z","timestamp":1612828800000},"content-version":"vor","delay-in-days":8,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100009398","name":"Rheinisch-Westf\u00e4lische Technische Hochschule Aachen | Medizinische Fakult\u00e4t, RWTH Aachen University","doi-asserted-by":"publisher","award":["PH START111\/17"],"award-info":[{"award-number":["PH START111\/17"]}],"id":[{"id":"10.13039\/501100009398","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Exp Mol Med"],"published-print":{"date-parts":[[2021,2]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Hypoxia is an underlying pathophysiological condition of a variety of devastating diseases, including acute ischemic stroke (AIS). We are faced with limited therapeutic options for AIS patients, and even after successful restoration of cerebral blood flow, the poststroke mortality is still high. More basic research is needed to explain mortality after reperfusion and to develop adjunct neuroprotective therapies.<jats:italic>Drosophila melanogaster (D.m.)<\/jats:italic>is a suitable model to analyze hypoxia; however, little is known about the impacts of hypoxia and especially of the subsequent reperfusion injury on the behavior and survival of<jats:italic>D.m<\/jats:italic>. To address this knowledge gap, we subjected two wild-type<jats:italic>D.m<\/jats:italic>. strains (Canton-S and Oregon-R) to severe hypoxia (&lt;0.3% O<jats:sub>2<\/jats:sub>) under standardized environmental conditions in a well-constructed hypoxia chamber. During posthypoxic reperfusion (21% O<jats:sub>2<\/jats:sub>), we assessed fly activity (evoked and spontaneous) and analyzed molecular characteristics (oxidative stress marker abundance, reactive oxygen species (ROS) production, and metabolic activity) at various timepoints during reperfusion. First, we established standard conditions to induce hypoxia in<jats:italic>D.m<\/jats:italic>. to guarantee stable and reproducible experiments. Exposure to severe hypoxia under defined conditions impaired the climbing ability and reduced the overall activity of both<jats:italic>D.m<\/jats:italic>. strains. Furthermore, a majority of the flies died during the early reperfusion phase (up to 24\u2009h). Interestingly, the flies that died early exhibited elevated activity before death compared to that of the flies that survived the entire reperfusion period. Additionally, we detected increases in ROS and stress marker (Catalase, Superoxide Dismutase and Heat Shock Protein 70) levels as well as reductions in metabolic activity in the reperfusion phase. Finally, we found that changes in environmental conditions impacted the mortality rate. In particular, decreasing the temperature during hypoxia or the reperfusion phase displayed a protective effect. In conclusion, our data suggest that reperfusion-dependent death might be associated with elevated temperatures, predeath activity, and oxidative stress.<\/jats:p>","DOI":"10.1038\/s12276-021-00565-3","type":"journal-article","created":{"date-parts":[[2021,2,9]],"date-time":"2021-02-09T19:13:01Z","timestamp":1612897981000},"page":"264-280","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["Posthypoxic behavioral impairment and mortality of Drosophila melanogaster are associated with high temperatures, enhanced predeath activity and oxidative stress"],"prefix":"10.1038","volume":"53","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5771-216X","authenticated-orcid":false,"given":"Pardes","family":"Habib","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Jung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gina Maria","family":"Wilms","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alma","family":"Kokott-Vuong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shahin","family":"Habib","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8903-0593","authenticated-orcid":false,"given":"J\u00f6rg B.","family":"Schulz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aaron","family":"Voigt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,2,9]]},"reference":[{"key":"565_CR1","unstructured":"Deepak, B., Ardekani, M. S., Shi, Q. & Movafagh, S. in Hypoxia and Human Diseases (eds Jing, Z. & Chi, Z.) Ch. 21 (IntechOpen, 2017)."},{"key":"565_CR2","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1055\/s-0038-1649503","volume":"38","author":"M Katan","year":"2018","unstructured":"Katan, M. & Luft, A. Global burden of stroke. Semin. Neurol. 38, 208\u2013211 (2018).","journal-title":"Semin. Neurol."},{"key":"565_CR3","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1016\/j.neuropharm.2017.08.036","volume":"134","author":"P Venkat","year":"2018","unstructured":"Venkat, P., Shen, Y., Chopp, M. & Chen, J. Cell-based and pharmacological neurorestorative therapies for ischemic stroke. Neuropharmacology 134, 310\u2013322 (2018).","journal-title":"Neuropharmacology"},{"key":"565_CR4","doi-asserted-by":"publisher","first-page":"1723","DOI":"10.1016\/S0140-6736(16)00163-X","volume":"387","author":"M Goyal","year":"2016","unstructured":"Goyal, M. et al. Endovascular thrombectomy after large-vessel ischaemic stroke: a meta-analysis of individual patient data from five randomised trials. Lancet 387, 1723\u20131731 (2016).","journal-title":"Lancet"},{"key":"565_CR5","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1056\/NEJMoa1706442","volume":"378","author":"RG Nogueira","year":"2018","unstructured":"Nogueira, R. G. et al. Thrombectomy 6 to 24\u2009h after stroke with a mismatch between deficit and infarct. N. Engl. J. Med. 378, 11\u201321 (2018).","journal-title":"N. Engl. J. Med."},{"key":"565_CR6","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1056\/NEJMoa1713973","volume":"378","author":"GW Albers","year":"2018","unstructured":"Albers, G. W. et al. Thrombectomy for stroke at 6 to 16\u2009h with selection by perfusion imaging. N. Engl. J. Med. 378, 708\u2013718 (2018).","journal-title":"N. Engl. J. Med."},{"key":"565_CR7","doi-asserted-by":"crossref","first-page":"3804979","DOI":"10.1155\/2018\/3804979","volume":"2018","author":"MS Sun","year":"2018","unstructured":"Sun, M. S. et al. Free radical damage in ischemia-reperfusion injury: an obstacle in acute ischemic stroke after revascularization therapy. Oxid. Med. Cell Longev. 2018, 3804979 (2018).","journal-title":"Oxid. Med. Cell Longev."},{"key":"565_CR8","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1111\/j.1749-6632.2010.05432.x","volume":"1184","author":"TE Lloyd","year":"2010","unstructured":"Lloyd, T. E. & Taylor, J. P. Flightless flies: Drosophila models of neuromuscular disease. Ann. N. Y Acad. Sci. 1184, e1\u2013e20 (2010).","journal-title":"Ann. N. Y Acad. Sci."},{"key":"565_CR9","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1146\/annurev.genet.39.110304.095804","volume":"39","author":"J Bilen","year":"2005","unstructured":"Bilen, J. & Bonini, N. M. Drosophila as a model for human neurodegenerative disease. Annu. Rev. Genet. 39, 153\u2013171 (2005).","journal-title":"Annu. Rev. Genet."},{"key":"565_CR10","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1007\/s12264-017-0173-7","volume":"34","author":"Y Xia","year":"2018","unstructured":"Xia, Y. et al. An efficient and reliable assay for investigating the effects of hypoxia\/anoxia on Drosophila. Neurosci. Bull. 34, 397\u2013402 (2018).","journal-title":"Neurosci. Bull."},{"key":"565_CR11","first-page":"Cd001247","volume":"2009","author":"HM Den Hertog","year":"2009","unstructured":"Den Hertog, H. M., van der Worp, H. B., Tseng, M. C. & Dippel, D. W. Cooling therapy for acute stroke. Cochrane Database Syst. Rev. 2009, Cd001247 (2009).","journal-title":"Cochrane Database Syst. Rev."},{"key":"565_CR12","doi-asserted-by":"publisher","first-page":"758","DOI":"10.1111\/jnc.13712","volume":"138","author":"E Dinter","year":"2016","unstructured":"Dinter, E. et al. Rab7 induces clearance of \u03b1-synuclein aggregates. J. Neurochem. 138, 758\u2013774 (2016).","journal-title":"J. Neurochem."},{"key":"565_CR13","doi-asserted-by":"publisher","first-page":"112978","DOI":"10.1016\/j.expneurol.2019.112978","volume":"320","author":"P Habib","year":"2019","unstructured":"Habib, P. et al. EPO regulates neuroprotective transmembrane BAX inhibitor-1 motif-containing (TMBIM) family members GRINA and FAIM2 after cerebral ischemia-reperfusion injury. Exp. Neurol. 320, 112978 (2019).","journal-title":"Exp. Neurol."},{"key":"565_CR14","doi-asserted-by":"publisher","first-page":"5456928","DOI":"10.1155\/2018\/5456928","volume":"2018","author":"MA Saraiva","year":"2018","unstructured":"Saraiva, M. A. et al. Exposure of Drosophila melanogaster to mancozeb induces oxidative damage and modulates Nrf2 and HSP70\/83. Oxid. Med. Cell Longev. 2018, 5456928 (2018).","journal-title":"Oxid. Med. Cell Longev."},{"key":"565_CR15","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1006\/bbrc.1998.9234","volume":"249","author":"NC Bacon","year":"1998","unstructured":"Bacon, N. C. et al. Regulation of the Drosophila bHLH-PAS protein Sima by hypoxia: functional evidence for homology with mammalian HIF-1 alpha. Biochem. Biophys. Res. Commun. 249, 811\u2013816 (1998).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"565_CR16","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1242\/bio.018226","volume":"6","author":"T Misra","year":"2017","unstructured":"Misra, T. et al. A genetically encoded biosensor for visualising hypoxia responses in vivo. Biol. Open 6, 296\u2013304 (2017).","journal-title":"Biol. Open"},{"key":"565_CR17","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1042\/BJ20050675","volume":"393","author":"N Arquier","year":"2006","unstructured":"Arquier, N. et al. Analysis of the hypoxia-sensing pathway in Drosophila melanogaster. Biochem J. 393, 471\u2013480 (2006).","journal-title":"Biochem J."},{"key":"565_CR18","doi-asserted-by":"publisher","first-page":"3878","DOI":"10.1091\/mbc.e09-01-0038","volume":"20","author":"M Irisarri","year":"2009","unstructured":"Irisarri, M. et al. Central role of the oxygen-dependent degradation domain of Drosophila HIFalpha\/Sima in oxygen-dependent nuclear export. Mol. Biol. Cell 20, 3878\u20133887 (2009).","journal-title":"Mol. Biol. Cell"},{"key":"565_CR19","doi-asserted-by":"publisher","first-page":"6842","DOI":"10.1128\/MCB.22.19.6842-6853.2002","volume":"22","author":"S Lavista-Llanos","year":"2002","unstructured":"Lavista-Llanos, S. et al. Control of the hypoxic response in Drosophila melanogaster by the basic helix-loop-helix PAS protein similar. Mol. Cell Biol. 22, 6842\u20136853 (2002).","journal-title":"Mol. Cell Biol."},{"key":"565_CR20","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1002\/(SICI)1096-9896(200002)190:3<255::AID-PATH526>3.0.CO;2-6","volume":"190","author":"DL Carden","year":"2000","unstructured":"Carden, D. L. & Granger, D. N. Pathophysiology of ischaemia-reperfusion injury. J. Pathol. 190, 255\u2013266 (2000).","journal-title":"J. Pathol."},{"key":"565_CR21","doi-asserted-by":"publisher","first-page":"65s","DOI":"10.1016\/S0002-9610(03)00306-4","volume":"187","author":"T Mustoe","year":"2004","unstructured":"Mustoe, T. Understanding chronic wounds: a unifying hypothesis on their pathogenesis and implications for therapy. Am. J. Surg. 187, 65s\u201370s (2004).","journal-title":"Am. J. Surg."},{"key":"565_CR22","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1056\/NEJMoa1411587","volume":"372","author":"OA Berkhemer","year":"2015","unstructured":"Berkhemer, O. A. et al. A randomized trial of intraarterial treatment for acute ischemic stroke. N. Engl. J. Med. 372, 11\u201320 (2015).","journal-title":"N. Engl. J. Med."},{"key":"565_CR23","doi-asserted-by":"publisher","first-page":"2285","DOI":"10.1056\/NEJMoa1415061","volume":"372","author":"JL Saver","year":"2015","unstructured":"Saver, J. L. et al. Stent-retriever thrombectomy after intravenous t-PA vs. t-PA alone in stroke. N. Engl. J. Med. 372, 2285\u20132295 (2015).","journal-title":"N. Engl. J. Med."},{"key":"565_CR24","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1056\/NEJMoa1414792","volume":"372","author":"BC Campbell","year":"2015","unstructured":"Campbell, B. C. et al. Endovascular therapy for ischemic stroke with perfusion-imaging selection. N. Engl. J. Med. 372, 1009\u20131018 (2015).","journal-title":"N. Engl. J. Med."},{"key":"565_CR25","doi-asserted-by":"publisher","first-page":"2296","DOI":"10.1056\/NEJMoa1503780","volume":"372","author":"TG Jovin","year":"2015","unstructured":"Jovin, T. G. et al. Thrombectomy within 8\u2009h after symptom onset in ischemic stroke. N. Engl. J. Med. 372, 2296\u20132306 (2015).","journal-title":"N. Engl. J. Med."},{"key":"565_CR26","doi-asserted-by":"publisher","first-page":"2254","DOI":"10.1161\/STROKEAHA.110.592535","volume":"41","author":"R Bhatia","year":"2010","unstructured":"Bhatia, R. et al. Low rates of acute recanalization with intravenous recombinant tissue plasminogen activator in ischemic stroke: real-world experience and a call for action. Stroke 41, 2254\u20132258 (2010).","journal-title":"Stroke"},{"key":"565_CR27","doi-asserted-by":"publisher","first-page":"2409","DOI":"10.1161\/STROKEAHA.116.014181","volume":"47","author":"P Seners","year":"2016","unstructured":"Seners, P. et al. Incidence and predictors of early recanalization after intravenous thrombolysis: a systematic review and meta-analysis. Stroke 47, 2409\u20132412 (2016).","journal-title":"Stroke"},{"key":"565_CR28","doi-asserted-by":"publisher","first-page":"1279","DOI":"10.1001\/jama.2016.13647","volume":"316","author":"JL Saver","year":"2016","unstructured":"Saver, J. L. et al. Time to treatment with endovascular thrombectomy and outcomes from ischemic stroke: a meta-analysis. Jama 316, 1279\u20131288 (2016).","journal-title":"Jama"},{"key":"565_CR29","doi-asserted-by":"publisher","first-page":"1796","DOI":"10.1161\/STROKEAHA.117.017286","volume":"49","author":"A Mizuma","year":"2018","unstructured":"Mizuma, A., You, J. S. & Yenari, M. A. Targeting reperfusion injury in the age of mechanical thrombectomy. Stroke 49, 1796\u20131802 (2018).","journal-title":"Stroke"},{"key":"565_CR30","doi-asserted-by":"publisher","first-page":"1952","DOI":"10.1161\/STROKEAHA.110.612358","volume":"42","author":"O Adeoye","year":"2011","unstructured":"Adeoye, O., Hornung, R., Khatri, P. & Kleindorfer, D. Recombinant tissue-type plasminogen activator use for ischemic stroke in the United States: a doubling of treatment rates over the course of 5 years. Stroke 42, 1952\u20131955 (2011).","journal-title":"Stroke"},{"key":"565_CR31","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.1161\/STROKEAHA.117.020273","volume":"49","author":"AP Jadhav","year":"2018","unstructured":"Jadhav, A. P. et al. Eligibility for endovascular trial enrollment in the 6- to 24-hour time window: analysis of a single comprehensive stroke center. Stroke 49, 1015\u20131017 (2018).","journal-title":"Stroke"},{"key":"565_CR32","doi-asserted-by":"publisher","first-page":"R442","DOI":"10.1152\/ajpregu.00389.2018","volume":"317","author":"JB Campbell","year":"2019","unstructured":"Campbell, J. B., Werkhoven, S. & Harrison, J. F. Metabolomics of anoxia tolerance in Drosophila melanogaster: evidence against substrate limitation and for roles of protective metabolites and paralytic hypometabolism. Am. J. Physiol. Regul. Integr. Comp. Physiol. 317, R442\u2013r450 (2019).","journal-title":"Am. J. Physiol. Regul. Integr. Comp. Physiol."},{"key":"565_CR33","doi-asserted-by":"crossref","unstructured":"Efficacy and safety of very early mobilisation within 24 h of stroke onset (AVERT): a randomised controlled trial. Lancet 386, 46\u201355 (2015).","DOI":"10.1016\/S0140-6736(15)60690-0"},{"key":"565_CR34","doi-asserted-by":"publisher","first-page":"472","DOI":"10.3390\/antiox3030472","volume":"3","author":"R Shirley","year":"2014","unstructured":"Shirley, R., Ord, E. N. & Work, L. M. Oxidative stress and the use of antioxidants in stroke. Antioxidants 3, 472\u2013501 (2014).","journal-title":"Antioxidants"},{"key":"565_CR35","doi-asserted-by":"publisher","first-page":"9761697","DOI":"10.1155\/2016\/9761697","volume":"2016","author":"I \u017dit\u0148anov\u00e1","year":"2016","unstructured":"\u017dit\u0148anov\u00e1, I. et al. Oxidative stress markers and their dynamic changes in patients after acute ischemic stroke. Oxid. Med. Cell Longev. 2016, 9761697 (2016).","journal-title":"Oxid. Med. Cell Longev."},{"key":"565_CR36","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1016\/j.neuint.2011.11.009","volume":"60","author":"I Olmez","year":"2012","unstructured":"Olmez, I. & Ozyurt, H. Reactive oxygen species and ischemic cerebrovascular disease. Neurochem. Int. 60, 208\u2013212 (2012).","journal-title":"Neurochem. Int."},{"key":"565_CR37","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1089\/neu.2008.0574","volume":"26","author":"TM Hemmen","year":"2009","unstructured":"Hemmen, T. M. & Lyden, P. D. Hypothermia after acute ischemic stroke. J. Neurotrauma 26, 387\u2013391 (2009).","journal-title":"J. Neurotrauma"},{"key":"565_CR38","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1007\/s11940-012-0201-x","volume":"14","author":"SS Song","year":"2012","unstructured":"Song, S. S. & Lyden, P. D. Overview of therapeutic hypothermia. Curr. Treat. Options Neurol. 14, 541\u2013548 (2012).","journal-title":"Curr. Treat. Options Neurol."},{"key":"565_CR39","doi-asserted-by":"publisher","first-page":"586","DOI":"10.3389\/fnins.2019.00586","volume":"13","author":"YJ Sun","year":"2019","unstructured":"Sun, Y. J., Zhang, Z. Y., Fan, B. & Li, G. Y. Neuroprotection by therapeutic hypothermia. Front. Neurosci. 13, 586 (2019).","journal-title":"Front. Neurosci."},{"key":"565_CR40","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1161\/01.STR.31.2.410","volume":"31","author":"C Hajat","year":"2000","unstructured":"Hajat, C., Hajat, S. & Sharma, P. Effects of poststroke pyrexia on stroke outcome: a meta-analysis of studies in patients. Stroke 31, 410\u2013414 (2000).","journal-title":"Stroke"},{"key":"565_CR41","doi-asserted-by":"publisher","DOI":"10.1186\/s12883-016-0760-7","volume":"16","author":"M Geurts","year":"2016","unstructured":"Geurts, M. et al. Temporal profile of body temperature in acute ischemic stroke: relation to infarct size and outcome. BMC Neurol. 16, 233 (2016).","journal-title":"BMC Neurol."}],"container-title":["Experimental &amp; Molecular Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/s12276-021-00565-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s12276-021-00565-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s12276-021-00565-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,23]],"date-time":"2024-08-23T22:51:29Z","timestamp":1724453489000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s12276-021-00565-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2]]},"references-count":41,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021,2]]}},"alternative-id":["565"],"URL":"https:\/\/doi.org\/10.1038\/s12276-021-00565-3","relation":{},"ISSN":["1226-3613","2092-6413"],"issn-type":[{"value":"1226-3613","type":"print"},{"value":"2092-6413","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,2]]},"assertion":[{"value":"13 August 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 December 2020","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 December 2020","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 February 2021","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}